Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MHB018A in Thyroid Eye Disease (OLE)
NCT07620405Phase 3Not yet recruiting
- Sponsor
- Minghui Pharmaceutical, Inc.
- Start
- Jul 2027
- Primary completion
- Jan 2030
01
Overview
A Phase 3 trial of MHB018A in thyroid eye disease (TED), sponsored by Minghui Pharmaceutical, Inc.. Planned start Jul 2027; status: not yet recruiting.
02
Drugs
MHB018A
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT07620405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07620405.